What Is a Pulmonary Embolism? A pulmonary embolism (PE) happens when a blood clot suddenly blocks an artery that supplies blood to your lungs. Pulmonary embolism happens when a blood clot travels ...
Pulmonary embolism (PE) is caused by emboli, which have originated from venous thrombi, travelling to and occluding the arteries of the lung. PE is the most dangerous form of venous thromboembolism, ...
VIENNA — The optimal course of treatment when managing acute, high-risk pulmonary embolism (PE) remains a contentious topic among respiratory specialists. Systemic thrombolysis, specifically using ...
Amid rapid changes in the field of acute pulmonary embolism (PE) treatment, the American Heart Association (AHA) has released a scientific statement summing up the current state of interventional ...
The right treatment for a pulmonary embolism depends on the size of the blood clot, complications you might be experiencing, and your risk of future blood clots. Options may include medications or ...
Bayer's Xarelto® (Rivaroxaban) Approved for the Treatment of Pulmonary Embolism (PE) and the Prevention of Recurrent Deep Vein Thrombosis (DVT) and PE in the EU Blood clots obstructing blood flow in ...
Please provide your email address to receive an email when new articles are posted on . As catheter-directed therapies have advanced in recent years, they are becoming a critical part of the strategy ...
Penumbra took the TCT (Transcatheter Cardiovascular Therapeutics) by storm on Sunday with the results of its landmark STORM-PE randomized controlled trial. The Alameda, CA-based company reported that ...
HOLLYWOOD, Fla. — Modern catheter-directed thrombolytic therapies are safe and effective for treating patients with acute massive or submassive pulmonary embolism, an expert said at the International ...
A pulmonary embolism (PE) is a blockage within an artery in the lungs. It is a potentially life threatening condition that requires prompt diagnosis and treatment. Pregnancy causes changes to hormones ...
LATHAM, N.Y.--(BUSINESS WIRE)-- AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, ...